Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 58 entries
View as:

A Study to Evaluate the Analgesic Efficacy and Safety of V120083 in Subjects With Osteoarthritis (OA) of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT03028870 Org: User:
Start: 03/14/17 End: 11/21/17 Due: 11/21/18

Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)

Phase: N/A Priority: Normal
NCT ID: NCT01688947 Org: User:
Start: 09/30/12 End: 04/30/14 Due: 04/30/15

Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT01358526 Org: User:
Start: 05/31/11 End: 11/30/12 Due: 11/30/13

To Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01101178 Org: User:
Start: 08/31/07 End: 11/30/07 Due: 11/30/08

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain.

Phase: N/A Priority: Normal
NCT ID: NCT00315887 Org: User:
Start: 04/30/99 End: 10/31/99 Due: 10/31/00

A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01101191 Org: User:
Start: 08/31/07 End: 01/31/08 Due: 01/31/09

An Analgesic Study to of V117957 for the Treatment of Postsurgical Pain Due to Third Molar Extraction

Phase: N/A Priority: Normal
NCT ID: NCT01900795 Org: User:
Start: 07/31/13 End: 11/30/13 Due: 11/30/14

Safety of BTDS in Subjects With Osteoarthritic (OA) Pain of Hip or Knee: A 6-Month Open-label Extension Phase

Phase: N/A Priority: Normal
NCT ID: NCT01141283 Org: User:
Start: 04/30/03 End: 07/31/04 Due: 07/31/05

Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain

Phase: N/A Priority: Normal
NCT ID: NCT00312572 Org: User:
Start: 06/30/03 End: 07/31/04 Due: 07/31/05

Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children

Phase: N/A Priority: Normal
NCT ID: NCT01324570 Org: User:
Start: 07/31/11 End: 05/31/16 Due: 05/31/17

Experimental Biomarker Study for Pain Thresholds

Phase: N/A Priority: Normal
NCT ID: NCT02695745 Org: User:
Start: 09/30/11 End: 01/31/12 Due: 01/31/13

Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement

Phase: N/A Priority: Normal
NCT ID: NCT00403234 Org: User:
Start: 11/30/06 End: 08/31/07 Due: 08/31/08

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

Phase: N/A Priority: Normal
NCT ID: NCT00315848 Org: User:
Start: 11/30/96 End: 12/31/99 Due: 12/31/00

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT04507204 Org: User:
Start: 07/30/20 End: 01/31/22 Due: 01/31/23

Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

Phase: N/A Priority: Normal
NCT ID: NCT00314652 Org: User:
Start: 06/30/99 End: 10/31/99 Due: 10/31/00

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT01427283 Org: User:
Start: 08/31/11 End: 10/31/14 Due: 10/31/15

Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.

Phase: N/A Priority: Normal
NCT ID: NCT00315835 Org: User:
Start: 10/31/96 End: 11/30/97 Due: 11/30/98

Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT01452529 Org: User:
Start: 10/31/11 End: 10/31/13 Due: 10/31/14

An Open-label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain

Phase: N/A Priority: Normal
NCT ID: NCT00465647 Org: User:
Start: 04/30/07 End: 04/30/10 Due: 04/30/11

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01999114 Org: User:
Start: 03/31/12 End: 10/31/12 Due: 10/31/13

Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children

Phase: N/A Priority: Normal
NCT ID: NCT04987762 Org: User:
Start: 08/03/21 End: 04/27/22 Due: 04/27/23

Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.

Phase: N/A Priority: Normal
NCT ID: NCT01400139 Org: User:
Start: 07/31/11 End: 10/31/13 Due: 10/31/14

Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg

Phase: N/A Priority: Normal
NCT ID: NCT06719986 Org: User:
Start: 10/03/22 End: 12/23/22 Due: 12/23/23

The Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets on QT /QTc Intervals in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02243241 Org: User:
Start: 11/30/12 End: 05/31/13 Due: 05/31/14

Safety, Pharmacokinetics (PK), and Effectiveness of Hydrocodone Bitartrate (HYD) Extended-Release Tablets in Children

Phase: N/A Priority: Normal
NCT ID: NCT02542098 Org: User:
Start: 01/31/17 End: 07/31/19 Due: 07/31/20